Billions of Dollars, Deliverables and California Stem Cell Spending Strategies
Neuropsychiatric disease to get $111 million, plus trying to answer "what are the most important outcomes for CIRM?"
It was a matter of “over-the-transom” versus “centralized planning” last week at the California stem cell agency as it moved toward final approval of a $111 million proposal to tackle the mechanisms behind diseases such as schizophrenia and autism.
A concept plan targeting those sorts of neuropsychiatric diseases cleared the agenc…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.